Biomarkers in psychiatry: drawbacks and potential for misuse
about
Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive DisorderBiomarkers in the diagnosis of ADHD--promising directionsOwnership and technical efficiency of hospitals: evidence from Ghana using data envelopment analysisBiomarkers of PTSD: military applications and considerations.Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions.Functional biomarkers of depression: diagnosis, treatment, and pathophysiologyTranslational epidemiology in psychiatry: linking population to clinical and basic sciences.Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression.A method for reproducible measurements of serum BDNF: comparison of the performance of six commercial assays.A method for biomarker measurements in peripheral blood mononuclear cells isolated from anxious and depressed mice: β-arrestin 1 protein levels in depression and treatment.Potential biomarkers in psychiatry: focus on the cholesterol system.The potential of biomarkers in psychiatry: focus on proteomics.Pharmaco-EEG: A Study of Individualized Medicine in Clinical Practice.Biomarkers for Major Depressive Disorder: Economic Considerations.The Utility of EEG in Attention Deficit Hyperactivity Disorder: A Replication Study.Altered plasma glutathione levels in bipolar disorder indicates higher oxidative stress; a possible risk factor for illness onset despite normal brain-derived neurotrophic factor (BDNF) levels.Continuous improvement after multiple mesenchymal stem cell transplantations in a patient with complete spinal cord injury.
P2860
Q26747511-A572E830-620E-49CC-A23A-2D3624B9C8F9Q28249420-7D83A43D-F81E-4977-88B9-CDDA4A725FACQ30795341-36C5C7E8-C0C7-47D6-84FC-15067505EA41Q34068752-006DDCB1-0A23-4027-8673-1DE8E49BA310Q34621808-F0F5D7B0-FE0A-45F3-8CF1-3273FC37E6B3Q35356872-1829A9BB-C081-43C8-B638-7135C81310CAQ35709432-40DC91D4-E44C-49E3-A190-56F841490C37Q35913907-E7FC64CB-1EBD-4D88-9073-14002B0675F5Q36361793-79521934-8EA6-4D49-8EEA-D278AD17166AQ37199234-22B13A08-3999-4C6E-8998-5D0956960ADFQ37981261-AC207B32-CC90-43E5-AF73-F73B36265905Q38172847-BA97458E-249B-4A88-B250-34C58E7EC31FQ44365022-695AFC63-C63F-4D27-8103-B46F694878BDQ47671635-414DC533-3E89-4A35-B70E-028CC8773EF8Q47873307-0DFE6237-A36B-4337-BDFD-D94F4B9AE7F8Q48363538-06C043D3-2238-4CE8-9BF6-3BA64493B5F5Q53570871-25590D5E-4F32-41E4-BBAC-FF0AA76FE136
P2860
Biomarkers in psychiatry: drawbacks and potential for misuse
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Biomarkers in psychiatry: drawbacks and potential for misuse
@ast
Biomarkers in psychiatry: drawbacks and potential for misuse
@en
type
label
Biomarkers in psychiatry: drawbacks and potential for misuse
@ast
Biomarkers in psychiatry: drawbacks and potential for misuse
@en
prefLabel
Biomarkers in psychiatry: drawbacks and potential for misuse
@ast
Biomarkers in psychiatry: drawbacks and potential for misuse
@en
P2860
P356
P1476
Biomarkers in psychiatry: drawbacks and potential for misuse
@en
P2093
Elissa Hamlat
Karen Vieira
P2860
P356
10.1186/1755-7682-3-1
P407
P577
2010-01-12T00:00:00Z